Influenza Immunization in Children and Young Adults: Clinical Reactions and Total and IgM Antibody Responses After Immunization With Whole-Virus or Split-Product Influenza Vaccines

American Journal of Diseases of Children

Volumn 136, Issue 6, 1982, Pages 513-517

  Bernstein, David I ^a   Zahradnik, John M ^a   Deangelis, Charles J ^a   Cherry, James D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN M; INFLUENZA VACCINE;

AGE; ANTIGEN ANTIBODY REACTION; HUMAN CELL; IMMUNIZATION; PRESCHOOL CHILD; PREVENTION; SCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; HEMAGGLUTINATION INHIBITION TESTS; HUMAN; IMMUNOGLOBULIN M; INFANT; INFLUENZA VACCINE; ORTHOMYXOVIRIDAE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020074883     PISSN: 0002922X     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpedi.1982.03970420037007     Document Type: Article

References (22)

1. 1. Gross AG: Reactogenicity and immunogenicity of bivalent influenza vaccine in oneand two-dose trials in children: A summary. J Infect Dis 1977;136 (suppl): 616-625.
2. 2. Wright PF, Dolin R, LaMontagne JR: Summary of clinical trials of influenza vaccines. J Infect Dis 1976;134: 633.
3. 3. Influenza vaccine 1981-82. MMWR 1981;30: 279-288.
4. 4. Boyer KM, Cherry JD, Wright PF, et al: Clinical reactions and serologic responses in healthy children aged 6 to 35 months after two-dose regimens of inactivated A/New Jersey/76 virus vaccines. J Infect Dis 1977;136 (suppl): 579-583.
5. 5. Boyer KM, Cherry JD, Welliver RC, et al: IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccines. J Infect Dis 1977;136 (suppl): 665-671.
6. 6. Barry DW, Mayner RE, Meisler JM, et al: Evaluation and control of vaccines for the National Influenza Immunization Program. J Infect Dis 1977;136 (suppl): 407-414.
7. 7. Bernstein DI, Zahradnik JM, DeAngelis CJ, et al: Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Pediatrics, to be published.
8. 8. Cherry JD, Feigin RD, Lobes LA, et al: Urban measles in the vaccine era: A clinical, epidemiologic and serologic study. J Pediatr 1972;81: 217-220.
9. 9. Cherry JD, Feigin RD, Shackelford PG, et al: A clinical and serologic study of 103 children with measles vaccine failure. J Pediatr 1973;82: 802-803.
10. 10. Parkman PD, Galasso GJ, Top FH Jr, et al: Summary of clinical trials of influenza vaccines. J Infect Dis 1976;134: 100-107.
11. 11. Kunz C, Hofmann H, Bachmayer H, et al: Clinical trials with a new influenza subunit vaccine in adults and children. Dev Biol Stand 1977;39: 297-302.
12. 12. Potter CW, Clark A, Jennings R, et al: Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children: Report to the medical research council committee on influenza and other respiratory virus vaccines. J Biol Stand 1980;8: 35-48.
13. 13. Gross PA, Ennis FA, Noble GR, et al: Influenza vaccine in unprimed children: Improved immunogenicity with fewer reactions following one high dose of split-product vaccine. J Pediatr 1980;97: 56-60.
14. 14. McLaren C, Grubbs GE, Staton E, et al: Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice. Infect Immun 1980;28: 171-177.
15. 15. Davenport FM: Antigenic enhancement of the extracted influenza viruses vaccine by A/PO4. Proc Soc Exp Biol Med 1968;127: 587-590.
16. 16. Neurath AR, Rubin BA: Viral structural components as immunogens of prophylactic value. Monogr Virol 1971;4: 1-87.
17. 17. Howard JG, Zola H, Christie GH, et al: Studies on immunological paralysis: V. The influence of molecular weight on the immunogenicity, tolerogenicity and antibody neutralizing activity of type III pneumococcal polysaccharide. Immunology 1971;21: 535-546.
18. 18. Webster RG, Kaell JA, Couch RB, et al: Influenza virus subunit vaccines: II. Immunogenicity and original antigenic sin in humans. J Infect Dis 1976;134: 48-58.
19. 19. Fazekas de St Groth S, Webster RG, Davenport FM: The antigenic subunits of influenza viruses: I. The homologous antibody response. J Immunol 1969;103: 1099-1115.
20. 20. Webster RG, Laver WG: Influenza virus subunit vaccines: Immunogenicity and lack of toxicity for rabbits of ether and detergent-disrupted virus. J Immunol 1966;96: 596-605.
21. 21. Nossal GJV, Ada GL, Austin CM: Antigens in immunity: II. Immunogenic properties of flagella, polymorized flagellin, and flagellin in the primary response. Aust J Exp Biol Med Sci 1964;42: 283-284.
22. 22. Herscowitz HB: Immunophysiology, cell function and cellular interaction, in Bellanti JA (ed): Immunology II. Philadelphia, WB Saunders Co, 1978, pp 151-202.